Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emerging Technology Poses Chief Strategic Challenge For GHTF

This article was originally published in The Gray Sheet

Executive Summary

Members of the Global Harmonization Task Force will be tasked with defining processes for identifying crucial scientific and regulatory issues involving select examples of new and emerging medical technologies

You may also be interested in...



Singapore Approvals: Asian “Barometer” Nation Begins To Regulate Devices

Singapore's medical device registration deadline may be extended beyond December 2003, due to staff constraints at the Health Sciences Authority's Center for Medical Device Regulation, Abbott Labs exec Carolyn Albertson told participants of the RAPS Global Awareness Asia conference June 24

Singapore Approvals: Asian “Barometer” Nation Begins To Regulate Devices

Singapore's medical device registration deadline may be extended beyond December 2003, due to staff constraints at the Health Sciences Authority's Center for Medical Device Regulation, Abbott Labs exec Carolyn Albertson told participants of the RAPS Global Awareness Asia conference June 24

GHTF Should Harmonize Emerging Areas of Device Regulation, EU Reps Say

The Global Harmonization Task Force should review new medical technology areas before countries develop separate regulatory practices for them, EUCOMED Director-General Michael Baker asserted at the Annual GHTF Conference in Ottawa, Canada Sept. 18-22.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016614

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel